Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
HK inno.N (195940 KS)
Watchlist
40
Analysis
Health Care
•
South Korea
HK inno.N Corp. develops and manufactures pharmaceuticals products. The Company develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products. HK inno.N conducts businesses across worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
HK inno.N
•
05 Jul 2021 10:45
HK Inno.N IPO Valuation Analysis
Our base case valuation of HK Inno.N is 75,534 won per share, which represents a 28% upside from the high end of the IPO price range. We have a...
Douglas Kim
Follow
303 Views
Share
bullish
•
HK inno.N
•
01 Jul 2021 16:51
HK Inno.N IPO Preview
HK Inno.N is getting ready for an IPO in the Korean stock market. The IPO price range is from 50,000 won to 59,000 won. The IPO deal size is from...
Douglas Kim
Follow
460 Views
Share
First
Previous
5
6
7
8
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x